Viemed Healthcare Inc(VMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 26.42 | EPS (ttm) | 0.37 | Insider Own | 13.94% | Shs Outstand | 38.1M | Perf Week | -1.33% |
| Market Cap | 0.37B | Forward P/E | 17.8 | EPS next Y | 31.45% | Insider Trans | -0.56% | Shs Float | 32.8M | Perf Month | 6.5% |
| Enterprise Value | 0.37B | PEG | 0.77 | EPS next Q | 0.12 | Inst Own | 74.49% | Short Float | 4.68% | Perf Quarter | -17.28% |
| Income | 0.01B | P/S | 1.22 | EPS this Y | 11.71% | Inst Trans | 3.86% | Short Ratio | 4.63 | Perf Half Y | -3.01% |
| Sales | 0.30B | P/B | 2.56 | EPS next 5Y | 23.09% | ROA | 7.46% | Short Interest | 1.54M | Perf YTD | 30.15% |
| Book/sh | 3.78 | P/C | 34.49 | EPS past 3/5Y | 32.77% -14.01% | ROE | 10.22% | 52W High | -23.31% ($12.61) | Perf Year | 51.33% |
| Cash/sh | 0.28 | P/FCF | 12.6 | Sales past 3/5Y | 24.87% 15.53% | ROIC | 9.45% | 52W Low | 59.83% ($6.05) | Perf 3Y | 55.22% |
| Dividend Est. | - | EV/EBITDA | 6.65 | EPS Y/Y TTM | 6.14% | Gross Margin | 56.95% | Volatility(W/M) | 3.19% 2.7% | Perf 5Y | 68.76% |
| Dividend TTM | - | EV/Sales | 1.23 | Sales Y/Y TTM | 25.21% | Oper. Margin | 8.47% | ATR (14) | 0.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.02 | EPS Q/Q | -12.5% | Profit Margin | 4.81% | RSI (14) | 53.11 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.13 | Sales Q/Q | 23.85% | SMA20 | 0.27% ($9.64) | Beta | 1.06 | Target Price | $12.5 |
| Payout | - | Debt/Eq | 0.08 | Earnings | 2026/11/5 | SMA50 | 4.82% ($9.23) | Rel Volume | 0.36 | Prev Close | $9.95 |
| Employees | 1382 | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | -41.67% 0.13% | SMA200 | 1.07% ($9.57) | Avg Volume(3M) | 0.33M | Price | $9.67 |
| IPO | 2018/1/4 | Option/Short | Yes/Yes | Trades | 1756 | Volume | 119,544 | Change | -2.81% |
Vimed Healthcare (VMD) is a U.S.-based medical device and home healthcare company that provides home non-invasive ventilation therapy and related medical device and consumable resupply services for patients with chronic respiratory diseases. Going beyond simple device sales, it operates an integrated care model in which clinical staff directly manage patients, and has established a position in a niche market on the back of high patient retention and strong insurance reimbursement approval capabilities.
Over the past 1 year, roughly in the middle
23% below its 1-year high.
Traded less than usual. That is 36% of its average volume.
Next earnings report: November 5
3 days to go.
VMD makes money exceptionally well
Of every $100 in sales, $8.47 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.7% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,642. Peers typically go for $2,776. It is about in line with its own 5-year average.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +68.8%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 74.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
SAWS AAM Sawgrass US Small Cap Quality Growth ETF 0.01% 
FDM First Trust Dow Jones Select Microcap Index Fund <0.01% 
ROSC Hartford Multifactor Small Cap ETF <0.01% 
SMLV State Street SPDR US Small Cap Low Volatility Index ETF <0.01% 
SYZ Lazard US Systematic Small Cap Equity ETF <0.01% It ranks #66 of 142 in the industry
Based on market cap of $368M.
RCEL#64 AVITA Medical Inc $389M PER - 
OFIX#65 Orthofix Medical Inc $369M PER - VMD#66 Viemed Healthcare Inc $368M PER 26.4 
CV#67 CapsoVision Inc $363M PER - 
MOBI#68 Mobia Medical Inc $352M PER - 
FAQ
What kind of company is VMD?
VMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of VMD?
The market cap of VMD is approximately $368M, ranking 3,408 within its sector.
What is the P/E ratio of VMD?
VMD has a P/E ratio of approximately 26.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for VMD?
VMD has recorded a 52-week high of $12.61 and a low of $6.05.
